Advertising Policy
Prior Publication
Peer Review Process
Declaration of Conflicting Interests Policy
Funding acknowledgements
Copyright, Licensing, and Permissions
Publication Fees
Corrections, Retractions, and Editorial Expressions of Concern
Commentaries, responses and rejoinders
Complaints and appeals procedure
Name change policy
Use of Generative Artificial Intelligence (AI)
Biolife Publisher is committed to upholding the integrity of all its publications. It is necessary therefore to agree on the standards of ethical behaviour expected from all parties involved in the publishing process; these include the author, the editor, the peer reviewer and the publisher.
Biolife Publisher follows the COPE Best Practice Guidelines on publishing ethics. Full details of these guidelines can be found on the COPE website.
Biolife Publisher does not tolerate plagiarism, or the publication of material that is libellous, illegal or which infringes the copyright or other rights of any third party. In addition, the manipulation of scientific data, tables, figures or any text for the purpose of knowingly providing incorrect information in order to manipulate the process of peer review is strictly prohibited.
Authorship
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data;
- Drafted the article or revised it critically for important intellectual content;
- Approved the version to be published;
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Please follow our guidelines in "instructions for Authors"
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
Authors publishing a paper with Biolife Publisher should certify that:
- their work is original and written by them;
- their work has not been previously published and has been submitted only to the journal;
- where material is taken from other sources (including their own published writing) the source is clearly cited and that where appropriate permission is obtained;
- their work does not infringe on any rights of others, including privacy rights and intellectual property rights;
- their data is true and not manipulated;
- their data is their own or that they have permission to use data reproduced in their paper;
- any real or apparent conflicting or competing interest is clearly stated on submission of their paper (this would include funding assistance);
- they adhere to all research ethics guidelines of their discipline, particularly where human or animal subjects are involved;
- they contact the Editor to identify and correct any material errors upon discovery, whether prior or subsequent to publication of their work;
- authorship of the paper is accurately represented, including ensuring that all individuals credited as authors participated in the actual authorship of the work and that all who participated are credited and have given consent for publication;
- the authors have read and agree to the Biolife Publisher copyright agreement.
Above all, authors should be transparent. For example, if an author is not sure whether her paper is original (for instance, whether it might constitute duplicate publication), she should inform the journal’s editor. If the editor decides it is appropriate to publish, the paper itself should state clearly any potential overlap.
Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company, and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose the use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
Declaration of conflicting interests
European Journal of Neurodegenerative Diseases requires a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations for the Disclosure of Financial and Non-Financial Relationships and Activities, and Conflicts of Interest.
Funding
European Journal of Neurodegenerative Diseases requires all authors to acknowledge their funding in a consistent fashion under a separate heading.
Inclusion and Confidentiality
The Editor or peer reviewer of any Biolife Publisher publication shall evaluate manuscripts on their intellectual content, irrespective of the race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors. The Editor and any editorial staff shall not disclose any confidential information concerning a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, or publisher, as appropriate. The content of any unpublished materials disclosed in a submitted manuscript is not to be used, either in whole or in part, in an editor’s own research without the express written consent of the submitting author.
Plagiarism Policy and Data Integrity
EJND has a zero tolerance policy for plagiarism. The journal rejects all forms of plagiarism, data fabrication, and falsification. During screenings, submissions must show an overall text similarity score below 15% and under 3% from any single outside source. Authors must clearly cite and limit reuse from their own prior work to avoid self-plagiarism.
Data Integrity and Verification
During evaluation, Reviewers or editors may request access to raw data, including original, unedited data files, clinical trial logs, or lab notes.
Image Standards: Authors must not enhance, crop out, or manipulate blots, gels, or microscopy images in a way that misleads the reader.
Statistical Rigor: The methods section must fully explain all software, algorithms, and statistical tests used to analyze patient cohorts or cellular models.
The journal publishes formal errata for honest errors or complete retractions for compromised data following COPE guidelines.
Misconduct
The publisher, Biolife Publisher, affirms that any misconduct, in the form of fabrication, falsification or plagiarism, jeopardizes the success of the entire scientific endeavor. Any questions raised with regard to possible misconduct or plagiarism will initially be evaluated by the editor(s) of the publication, in consultation with the manuscript’s peer reviewer(s) if appropriate. If deemed appropriate, the matter will be taken up with the institution where the scientific work in question was performed. In principle, matters will be reviewed in accordance with the institutional procedures for handling allegations of misconduct. At all stages, every effort should be made to ensure that the process is fair and just, both for those who have been accused of misconduct and for those who have raised the issue of scientific misconduct. In the event that a published article must be retracted or corrected, a statement of retraction or correction, usually in the form of an erratum, will be published. Articles may be removed from the publication if deemed appropriate.
Biolife Publisher expects authors to abide by the general ethics polices outlined by The Council of Science Editors (CSE) and COPE. Please use the links below as references.
Science Editor-Publications released by the Council of Science Editors
COPE-General approach to publication ethics for the editorial office
Responsible research publication: International standards for authors
